I note also that there have been plenty of Aussie companies that focused on excellent R&D at the expense of commercialisation that are no longer with us.
PolyNovo has escaped that fate and in the years to come will have, no doubt, a broad portfolio of NovoSorb products just because in its early days it focused on bringing in the dollars.
- Forums
- ASX - By Stock
- PNV
- Medtronic has entered the market for resorbable mesh Ventral Hernia Repair
Medtronic has entered the market for resorbable mesh Ventral Hernia Repair, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.52 |
Change
-0.020(0.79%) |
Mkt cap ! $1.760B |
Open | High | Low | Value | Volume |
$2.55 | $2.56 | $2.52 | $1.078M | 425.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 22458 | $2.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.53 | 20624 | 37 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 23136 | 2.520 |
16 | 48004 | 2.510 |
18 | 93253 | 2.500 |
14 | 179134 | 2.490 |
6 | 33645 | 2.480 |
Price($) | Vol. | No. |
---|---|---|
2.530 | 20618 | 36 |
2.540 | 43481 | 20 |
2.550 | 73989 | 21 |
2.560 | 86077 | 14 |
2.570 | 172951 | 10 |
Last trade - 12.57pm 13/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online